new to the whole stocks,3 months in. let me know what you guys think. thinking of getting in if it doesn't go past 113.50 wait for bounce to pass 117 then im in. looking at about minimum 10% gain. any tips advice, Id really appreciate it . Again im new and first idea ive come up with
new to the whole stocks,3 months in. let me know what you guys think. thinking of getting in if it doesn't go past 113.50 wait for bounce to pass 117 then im in. looking at about minimum 10% gain. any tips advice, Id really appreciate it . Again im new and first idea ive come up with
INCY has good analyst recommendations and it could be a potential long trade.
MACD cross with RSI in bull range. Should test major DTL (125+)
I will be paying a lot of attention to biotech throughout 2017 with trumps victory, i believe he may have opened the door on this sector. there are many reasons to support this please do some research if you are interested. There are quite a few midcap stocks on my list. Incy here is just one of them which saw a near 20% rise on trumps win and looks to be forming...
After a huge run, Incyte Pharmaceuticals is tired and this flag suggest more downside to come.
INCY has very high (3412) P/E ration & in the technical side INCY is forming a downward pennant in longer frame & a upward channel. Both suggesting a decline, money-flow is showing neg-divergence & running strongly downward. We think it will decline around 60 or lower You can check our detailed analysis on INCY in the trading room/ Executive summery link...
Earnings were good, guidance raised, analysts raising PT's. Nice entry here for a starter.
I ENTER SHORT NEXT TIME THE HOURLY STO IS GOING DOWN
Friends, Notes on chart. I'm looking for the channel break to be honest. Which is the bigger picture. Went short personally @ 103.70's (After an intraday retest of the highs failed and shorts continued on 28.04.2015.) Tom
INCY isn't quite there yet - as a good linear trending stock. The daily 50ma is beginning to look like it may be offering consistent support but it is early days. There was congestion around the $50 and daily 200ma zone for several months in the middle of 2014 - which was some way off the February 2014 high of just above $70. Towards the end of last year price...
1. Relative Strength Analysis: INCY has outperformed both the SPY and XLV (Health Care Sector Spyder) over YTD, 6 and 12 month periods. 2. Wyckoff re-accumulation, 2nd break of CREEK after a successful test of supply in the form of the "Back Up to the Creek" (BUC). 3. A longer term cup n handle pattern, with the handle shown as a flag pattern after the breakout....
Simply this next leg post breakout recently may not be completed. Breaking out this week could still be very powerful. Strong expanding volume.